Follow
Curt Balch
Curt Balch
Bioscience Advising
Verified email at bioscienceadvising.com - Homepage
Title
Cited by
Cited by
Year
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
S Zhang, C Balch, MW Chan, HC Lai, D Matei, JM Schilder, PS Yan, ...
Cancer research 68 (11), 4311-4320, 2008
16652008
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
M Li, C Balch, JS Montgomery, M Jeong, JH Chung, P Yan, THM Huang, ...
BMC medical genomics 2, 1-13, 2009
2392009
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer
F Fang, C Balch, J Schilder, T Breen, S Zhang, C Shen, L Li, ...
Cancer 116 (17), 4043-4053, 2010
1912010
Minireview: epigenetic changes in ovarian cancer
C Balch, F Fang, DE Matei, THM Huang, KP Nephew
Endocrinology 150 (9), 4003-4011, 2009
1742009
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance
F Xin, M Li, C Balch, M Thomson, M Fan, Y Liu, SM Hammond, S Kim, ...
Bioinformatics 25 (4), 430-434, 2009
1422009
Growth inhibition of ovarian tumor–initiating cells by niclosamide
YT Yo, YW Lin, YC Wang, C Balch, RL Huang, MWY Chan, HK Sytwu, ...
Molecular cancer therapeutics 11 (8), 1703-1712, 2012
1382012
Detection of PIWI and piRNAs in the mitochondria of mammalian cancer cells
CH Kwon, H Tak, M Rho, HR Chang, YH Kim, KT Kim, C Balch, EK Lee, ...
Biochemical and biophysical research communications 446 (1), 218-223, 2014
802014
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
MJ Kwon, SS Kim, YL Choi, HS Jung, C Balch, SH Kim, YS Song, ...
Carcinogenesis 31 (6), 974-983, 2010
792010
Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells
SA Bapat, V Jin, N Berry, C Balch, N Sharma, N Kurrey, S Zhang, F Fang, ...
Epigenetics 5 (8), 716-729, 2010
652010
A rationally designed histone deacetylase inhibitor with distinct antitumor activity against ovarian cancer
YT Yang, C Balch, SK Kulp, MR Mand, KP Nephew, CS Chen
Neoplasia 11 (6), 552-IN9, 2009
652009
Natural polyphenols in cancer chemoresistance
SA Hussain, AA Sulaiman, C Balch, H Chauhan, QM Alhadidi, AK Tiwari
Nutrition and cancer 68 (6), 879-891, 2016
572016
Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells
K McIntosh, C Balch, AK Tiwari
Expert opinion on drug metabolism & toxicology 12 (6), 633-644, 2016
532016
Epigenetic “bivalently marked” process of cancer stem cell‐driven tumorigenesis
C Balch, KP Nephew, THM Huang, SA Bapat
Bioessays 29 (9), 842-845, 2007
472007
TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions
PH Su, YW Hsu, RL Huang, LY Chen, TK Chao, CC Liao, CW Chen, ...
Cancer letters 450, 53-62, 2019
402019
A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer
S Nam, HR Chang, HR Jung, Y Gim, NY Kim, R Grailhe, HR Seo, HS Park, ...
Cancer letters 356 (2), 880-890, 2015
372015
Epigenetic targeting therapies to overcome chemotherapy resistance
C Balch, KP Nephew
Epigenetic Alterations in Oncogenesis, 285-311, 2012
352012
Pyrimido [1 ″, 2 ″: 1, 5] pyrazolo [3, 4-b] quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells
C Karthikeyan, R Malla, CR Ashby Jr, H Amawi, KL Abbott, J Moore, ...
Cancer letters 376 (1), 118-126, 2016
322016
The epigenomics of embryonic pathway signaling in colorectal cancer
C Balch, JB Ramapuram, AK Tiwari
Frontiers in pharmacology 8, 262162, 2017
292017
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
HR Chang, S Nam, J Lee, JH Kim, HR Jung, HS Park, S Park, YZ Ahn, ...
Oncotarget 7 (49), 81435, 2016
212016
Methyl group acceptance assay for the determination of global DNA methylation levels
KP Nephew, C Balch, DG Skalnik
DNA Methylation: Methods and Protocols, 35-41, 2009
212009
The system can't perform the operation now. Try again later.
Articles 1–20